(Q37575099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Technology and the issue of cost/benefit in diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Angelika Mohn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Francesco Chiarelli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

Diabetes - Metabolism: Research and Reviews

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

25 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

S34-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

4 February 2020

cites work

1 reference

Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database

21 January 2018

1 reference

Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology?

21 January 2018

1 reference

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

7 January 2021

Non-insulin dependent diabetes mellitus in African-American youths of Arkansas

1 reference

7 January 2021

Type 2 diabetes in obese white children

1 reference

7 January 2021

Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat.

1 reference

7 January 2021

Economic costs of diabetes in the US in 2002.

1 reference

7 January 2021

Economic costs of diabetes in the U.S. In 2007.

1 reference

7 January 2021

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

7 January 2021

Cost-of-illness studies in diabetes mellitus

1 reference

7 January 2021

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

7 January 2021

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

1 reference

7 January 2021

The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales

1 reference

7 January 2021

Diabetes: the cost of illness in Sweden

1 reference

7 January 2021

Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4)

1 reference

7 January 2021

Environmental Tobacco Smoke and Absenteeism Related to Respiratory Illness in Schoolchildren

1 reference

7 January 2021

Separation anxiety disorder in young children: a longitudinal and family analysis

1 reference

7 January 2021

1 reference

7 January 2021

Schooling, intelligence, and income

1 reference

7 January 2021

The social and economic consequences of childhood-onset Type 1 diabetes mellitus across the lifecourse: a systematic review.

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

7 January 2021

Predictors of health care costs in adults with diabetes.

1 reference

7 January 2021

Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group

1 reference

7 January 2021

The role of new technologies in treating children and adolescents with type 1 diabetes mellitus

1 reference

7 January 2021

Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring

1 reference

7 January 2021

A review of human and analogue insulin trials

1 reference

7 January 2021

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia

1 reference

7 January 2021

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

7 January 2021

Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials

1 reference

7 January 2021

An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK

1 reference

7 January 2021

Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada

1 reference

7 January 2021

Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH

1 reference

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

1 reference

7 January 2021

Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.

1 reference

7 January 2021

Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents

1 reference

7 January 2021

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness

1 reference

7 January 2021

Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?

1 reference

7 January 2021

Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

1 reference

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia

1 reference

7 January 2021

Predictors of control of diabetes: monitoring may be the key.

1 reference

7 January 2021

Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria

1 reference

7 January 2021

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

1 reference

7 January 2021

Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study

1 reference

7 January 2021

Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study

1 reference

7 January 2021

Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor

1 reference

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

7 January 2021

Use of the GlucoWatch biographer in children with type 1 diabetes

1 reference

7 January 2021

Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes

1 reference

7 January 2021

Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems

1 reference

7 January 2021

Blood volumes and pain following capillary punctures in children and adolescents with diabetes

1 reference

7 January 2021

Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes

1 reference

7 January 2021

The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients

1 reference

7 January 2021

Benefits of information technology-enabled diabetes management

1 reference

7 January 2021

Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial

1 reference

7 January 2021

Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

1 reference

7 January 2021

Does continuous glucose monitoring have clinical utility in contemporary management of diabetes?

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662616%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference